中智药业(03737)发布2024年度业绩报告,全年收益为22.15亿元人民币,同比增长8.05%;然而,股东应占溢利为9521.2万元,同比大幅减少41.51%。每股基本盈利为0.11元,并计划派发末期股息每股5港仙。制药业务收益增长显著,达到16.24亿元,占总收益的73.3%,较去年增加约14.7%。公司表示,收益增长主要得益于销售战略的调整,包括加大对传统饮片市场的投入,同时继续以破壁饮片...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.